Dragonfruit AI revolutionizes retail analytics with their upgraded Spatial Retail Insights application, leveraging AI and existing video systems to unlock deep customer insights for retailers.

Berachain emerges as a DeFi leader during the recent crypto bull run, securing unicorn status with a staggering $1.5 billion valuation.

Discover the latest trend powering urban transit: the micro electric vehicle market is set to surge by over 1,500 thousand units by 2027, featuring revolutionary models and eco-friendly tech.

Explore BIGO Ads' advanced advertising solutions at GDC 2024 to boost your game's revenue and unlock new user acquisition strategies with cutting-edge AI and analytics.

In a landmark initiative, over 60 entities including leading cybersecurity firms and non-profits form a formidable alliance to enhance defenses and predictive capabilities against advanced cyber threats, marking a pivotal step towards global digital security.

Seegene Inc. partners with Springer Nature to award innovative research grants focused on pioneering diagnostic solutions for infectious diseases, reinforcing the global commitment towards a disease-free future.

In a groundbreaking medical stride, Professors Sir David Klenerman and Sir Shankar Balasubramanian have been honored with the 2024 Novo Nordisk Prize for their seminal work in reducing genome sequencing time to a mere hour. Their transformative discoveries promise a new dawn for personalized healthcare and disease management.

A recent breakthrough in lithium-sulfur (Li-S) battery technology promises to transform the energy storage landscape, offering a significant leap in battery life, efficiency, and sustainability. With potential applications ranging from electric vehicles to renewable energy systems, this advancement is poised to redefine how we manage and utilize power in an eco-conscious era.

CCELL® revolutionizes the European cannabis market by showcasing its latest vaporization technologies at Spannabis, Europe's premier cannabis fair.

Selvita S.A. announces a significant strategic expansion into therapeutic antibody discovery, showcasing an ambitious move to enhance their biologic drug discovery and development capabilities. The initiative, indicative of Selvita's commitment to innovation, positions the company as a leader in biologic research and caters to the growing needs of the pharmaceutical industry.